News
4h
Stockhead on MSNDr Boreham’s Crucible: Sizing up the opportunity for ASX biotech AdheriumPlenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...
It’s been a fantastic ride. I’ve enjoyed every moment of it,” Refiloe Masekela, MD, PhD, chair of the Pan African Thoracic Society, told Healio at the American Thoracic Society International ...
The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.
4don MSN
According to NHS GP Dr Sooj, if you have asthma or chronic obstructive pulmonary disease (COPD) you should think twice before ...
Emphysema is a slow killer. Severe emphysema even alienates family members as the patients relegate themselves to the length of their oxygen tubing and suffer through an acquired mutism from ...
Influential expert in respiratory medicine. Born on June 11, 1947, in Tshwane, South Africa, he died on Jan 18, 2025, in Cape Town, South Africa, aged 77 years.
2d
GB News on MSNMillions of Britons issued health alert over 'thunder fever' as nation pummelled by stormsMore than seven million Britons have been urged to strap themselves in for a tumultuous weekend ahead as thunderstorms ...
They can no longer reside in their apartment, not due to destruction, but because of hazardous indoor air quality for at-risk ...
Practice managers play a vital role in early COPD intervention and community care. Discover how proactive strategies can ...
Liquidia (LQDA) stock and United Therapeutics (UTHR) stock fall as Insmed (INSM) post positive data for a rival pulmonary ...
If you meet the criteria for lung cancer screening — meaning you are or have a history of being a heavy smoker, and are between 50 and 80 years old — experts recommend an annual low-dose ...
Nuvation is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results